Galena Biopharma, Inc. (GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced the closing of its previously announced underwritten public offering of 24,358,974 shares of common stock, and warrants to purchase an aggregate of 12,179,487 shares of common stock at an exercise price of $2.08 per share.

For Martha Stewart, a very good thing appears about to happen — and her stock price is soaring to its highest price since mid-May 2010. It closed at $6.36 on Monday, up 14 percent on the day.

(Reuters) - Western Digital Corp, the world's No. 1 hard-disk drive maker, reported second-quarter results slightly ahead of Wall Street expectations on strong demand for its solid-state drives from enterprise customers.

Conkwest, Inc., the Natural Killer Cell Company of the West, developing the proprietary Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) as an immuno-oncology therapeutic, announces that Dr. Patrick Soon-Shiong, NantWorks founder, physician scientist and biotechnology entrepreneur, has entered into a definitive agreement to purchase approximately $48 million of the Company's Class A Common Stock.

LAS VEGAS, NV--(Marketwired - Mar 12, 2014) - Noble Financial Capital Markets (Noble) announced today that the company will host the first Financial Forum at the NAB SHOW since 1969.

Conkwest, Inc., the Natural Killer Cell Company of the West, developing the proprietary Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) as an immuno-oncology therapeutic, announces that Dr. Patrick Soon-Shiong, NantWorks founder, physician scientist and biotechnology entrepreneur, has entered into a definitive agreement to purchase approximately $48 million of the Company's Class A Common Stock.

Ad sales for Charlotte-area TV stations fell 12 percent last year, according to figures compiled by consulting firm BIA Kelsey. Despite the decline, industry experts and station executives agree that the Charlotte market remains strong.